Sandoz Group AG
🇨🇭XSWX.SDZSwitzerlandHealthcare
PriceCHF 71.16+0.38 (+0.54%)
Latest anomalies
Negative 1 detected in the last 120 days
- High: 1
- Medium: 0
- Low: 0
Volume: a spike above the 20-day average
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH1243598427
- CUSIP
- Not reported
Company
- Employees
- 20,000
- Headquarters
- Basel, Switzerland
- Website
- https://www.sandoz.com
Market
- Shares outstanding
- 432.7M
- Market cap
- CHF 30.65B
Key dates
- Next earnings
- Feb 25, 2027
Highlights
- Market cap
- CHF 30.65B
- EPS LTM
- CHF 0.18
- P/E LTM
- 386.59calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 1.05%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CHF 12.24B-9.88%down year on year
- Net income
- CHF 79.55M-90.98%down year on year
- Gross margin
- 45.63%-3.6%down year on year
- Free cash flow
- CHF 198M-79.94%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Sandoz Group AG is a company in the healthcare sector, listed on SIX Swiss Exchange (Switzerland) under the ticker SDZ. Its market capitalisation is CHF 30.65B, from 432.7M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 43.86 and CHF 75.90, and the last close of CHF 71.16 sits 85% of the way up that range. The company is headquartered in Basel, Switzerland, and employs about 20,000 people. The same company also trades as D8Y0 on Frankfurt Stock Exchange, and as 0SAN on London Stock Exchange.
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.